Literature DB >> 28532760

Research Techniques Made Simple: High-Throughput Sequencing of the T-Cell Receptor.

Tiago R Matos1, Menno A de Rie2, Marcel B M Teunissen2.   

Abstract

High-throughput sequencing (HTS) of the T-cell receptor (TCR) is a rapidly advancing technique that allows sensitive and accurate identification and quantification of every distinct T-cell clone present within any biological sample. The relative frequency of each individual clone within the full T-cell repertoire can also be studied. HTS is essential to expand our knowledge on the diversity of the TCR repertoire in homeostasis or under pathologic conditions, as well as to understand the kinetics of antigen-specific T-cell responses that lead to protective immunity (i.e., vaccination) or immune-related disorders (i.e., autoimmunity and cancer). HTS can be tailored for personalized medicine, having the potential to monitor individual responses to therapeutic interventions and show prognostic and diagnostic biomarkers. In this article, we briefly review the methodology, advances, and limitations of HTS of the TCR and describe emerging applications of this technique in the field of investigative dermatology. We highlight studying the pathogenesis of T cells in allergic dermatitis and the application of HTS of the TCR in diagnosing, detecting recurrence early, and monitoring responses to therapy in cutaneous T-cell lymphoma.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28532760      PMCID: PMC5912324          DOI: 10.1016/j.jid.2017.04.001

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.

Authors:  Alain H Rook; Joel M Gelfand; Joel C Gelfand; Maria Wysocka; Andrea B Troxel; Bernice Benoit; Christian Surber; Rosalie Elenitsas; Marie A Buchanan; Deborah S Leahy; Rei Watanabe; Ilan R Kirsch; Ellen J Kim; Rachael A Clark
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

2.  Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.

Authors:  Harlan S Robins; Paulo V Campregher; Santosh K Srivastava; Abigail Wacher; Cameron J Turtle; Orsalem Kahsai; Stanley R Riddell; Edus H Warren; Christopher S Carlson
Journal:  Blood       Date:  2009-08-25       Impact factor: 22.113

3.  High-throughput pairing of T cell receptor α and β sequences.

Authors:  Bryan Howie; Anna M Sherwood; Ashley D Berkebile; Jan Berka; Ryan O Emerson; David W Williamson; Ilan Kirsch; Marissa Vignali; Mark J Rieder; Christopher S Carlson; Harlan S Robins
Journal:  Sci Transl Med       Date:  2015-08-19       Impact factor: 17.956

4.  T-cell receptor gene rearrangement detection in suspected cases of cutaneous T-cell lymphoma.

Authors:  Pooja Chitgopeker; Debjani Sahni
Journal:  J Invest Dermatol       Date:  2014-04       Impact factor: 8.551

5.  Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.

Authors:  Wen-Hung Chung; Ren-You Pan; Mu-Tzu Chu; See-Wen Chin; Yu-Lin Huang; Wei-Chi Wang; Jen-Yun Chang; Shuen-Iu Hung
Journal:  J Invest Dermatol       Date:  2015-05-06       Impact factor: 8.551

6.  Common clonal origin of central and resident memory T cells following skin immunization.

Authors:  Olivier Gaide; Ryan O Emerson; Xiaodong Jiang; Nicholas Gulati; Suzanne Nizza; Cindy Desmarais; Harlan Robins; James G Krueger; Rachael A Clark; Thomas S Kupper
Journal:  Nat Med       Date:  2015-05-11       Impact factor: 53.440

7.  TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL.

Authors:  Ilan R Kirsch; Rei Watanabe; John T O'Malley; David W Williamson; Laura-Louise Scott; Christopher P Elco; Jessica E Teague; Ahmed Gehad; Elizabeth L Lowry; Nicole R LeBoeuf; James G Krueger; Harlan S Robins; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2015-10-07       Impact factor: 17.956

8.  IMGT, the international ImMunoGeneTics information system.

Authors:  Marie-Paule Lefranc; Véronique Giudicelli; Chantal Ginestoux; Joumana Jabado-Michaloud; Géraldine Folch; Fatena Bellahcene; Yan Wu; Elodie Gemrot; Xavier Brochet; Jérôme Lane; Laetitia Regnier; François Ehrenmann; Gérard Lefranc; Patrice Duroux
Journal:  Nucleic Acids Res       Date:  2008-10-31       Impact factor: 16.971

  8 in total
  7 in total

1.  Clonal enrichments of Vδ2- γδ T cells in Mycobacterium tuberculosis-infected human lungs.

Authors:  Corinna A Kulicke; Deborah A Lewinsohn; David M Lewinsohn
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.

Authors:  Christoph Groth; Lenneke F J van Groningen; Tiago R Matos; Manita E Bremmers; Frank W M B Preijers; Harry Dolstra; Christian Reicherts; Nicolaas P M Schaap; Eric H G van Hooren; Joanna IntHout; Rosalinde Masereeuw; Mihai G Netea; John E Levine; George Morales; James L Ferrara; Nicole M A Blijlevens; Ypke V J M van Oosterhout; Matthias Stelljes; Walter J F M van der Velden
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-03       Impact factor: 5.742

3.  Diagnostic Value of Genotypic Analysis in Primary Cutaneous Lymphomas using Standardized BIOMED-2 Polymerase Chain Reaction Protocols: Experience in Daily Clinical Practice.

Authors:  Daniel López Aventín; Fernando Gallardo; Luis Colomo; Ester Moragón; María Carmen Vela; Xavier Duran Jordà; Beatriz Bellosillo; Ramon M Pujol
Journal:  Acta Derm Venereol       Date:  2021-05-19       Impact factor: 3.875

Review 4.  Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.

Authors:  Nadin Younes; Duaa W Al-Sadeq; Hadeel Al-Jighefee; Salma Younes; Ola Al-Jamal; Hanin I Daas; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2020-05-26       Impact factor: 5.048

5.  Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response.

Authors:  Laura Bierhansl; Tobias Ruck; Steffen Pfeuffer; Catharina C Gross; Heinz Wiendl; Sven G Meuth
Journal:  Neurol Res Pract       Date:  2019-12-13

6.  Profiling the peripheral blood T cell receptor repertoires of gastric cancer patients.

Authors:  Mengyao Wang; Peng Gao; Laifeng Ren; Jingjing Duan; Silu Yang; Haina Wang; Hongxia Wang; Junning Sun; Xiaoyan Gao; Bo Li; Shuaicheng Li; Wen Su
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

7.  Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation.

Authors:  Simona Pagliuca; Carmelo Gurnari; Sanghee Hong; Ran Zhao; Sunisa Kongkiatkamon; Laila Terkawi; Misam Zawit; Yihong Guan; Hassan Awada; Ashwin Kishtagari; Cassandra M Kerr; Thomas LaFramboise; Bhumika J Patel; Babal K Jha; Hetty E Carraway; Valeria Visconte; Navneet S Majhail; Betty K Hamilton; Jaroslaw P Maciejewski
Journal:  JCI Insight       Date:  2021-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.